Exelixis
EXEL
#1552
Rank
S$18.41 B
Marketcap
S$73.25
Share price
1.47%
Change (1 day)
28.29%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company